GC Biopharma Corp.

006280.KS · Moat type: REGULIERUNG

MoatScore

0/10

Fair Value

80,290 KRW (≈ 56.20 USD)

Margin of Safety

-52.9 %

Rating

MEIDEN

GC Biopharma Corp. (006280.KS) is a South Korean biopharmaceutical manufacturer that primarily develops, produces, and distributes blood products (plasma derivatives), vaccines, and biopharmaceuticals – a capital-intensive business model based on regulatory approvals, production licenses, and clinical expertise.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.